Raids conducted in Punjab State by FDA to check the illegal sale of Habit-Forming Drugs

The statewide raids were made by the Punjab state’s Food and Drug Administration and the results are very disappointed as many of the chemists were selling habit-forming drugs without any prescription illegally.

FDA team found Chemists were confiscated a large number of abused drugs and collected samples of the medicines for quality check. FDA officials also seized 10 lakhs worth of Alprazolam and Propranolol drug worth Rs 3.9 lakh from chemist Maruti Pharma in Muktsar.

The chemist was failed to show any bill for these stored stock. Cardilax-Alprazolam and propranolol tablets worth Rs 1 lakh were seized from another chemist Rinku Pharma.

Team also collected samples from various districts like Bathinda, Fazilka, Ludhiana and SBS Nagar. The team will send these samples to the government laboratory for quality check. Raid results again proved that there is a need to take strong action among them as drug consumption is increasing day by day in the state.

These kind of activities are becoming the reasons for the slow killing of a youth and that will be putting their future to the dark. Many small courier companies are also involved in transferring these habit-forming drugs such as buprenorphine and pain reliever tramadol. Smugglers also using public transport like AC buses and trains to smuggle these drugs to earn bucks of money.

The Punjab state has also initiated interstate coordination with neighboring states to check the menace.

Related Posts

  • Pharma
  • April 18, 2024
  • 22 views
Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

Ahmedabad: The growth of the pharmaceutical industry in Gujarat has continued unabated in the financial year 2023-24, with the Gujarat State Food and Drug Control Administration (FDCA) issuing 133 approvals…

  • Pharma
  • April 18, 2024
  • 28 views
DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

New Delhi: The Drugs Controller General (India) (DCGI) has informed all state drug regulators that the Central regulatory authority has not approved manufacturing and marketing of antibiotic combination of meropenem 1 mg…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

Ramdev, Balkrishna Acharya Ready For ‘Public Apology’; Supreme Court Next Hearing On April 23

Ramdev, Balkrishna Acharya Ready For ‘Public Apology’; Supreme Court Next Hearing On April 23

Organovo’s Drug Significantly Reduces Liver Fat In NASH Study

Organovo’s Drug Significantly Reduces Liver Fat In NASH Study

Significant Decline In Pharma Deals In Q1

Significant Decline In Pharma Deals In Q1